Urinary β-core hCG: Screening for aneuploidies in early pregnancy (11-14 weeks' gestation)

Prenatal Diagnosis

Volumn 17, Issue 5, 1997, Pages 401-405

  Macintosh, M C M ^a,c   Nicolaides, K H ^a   Noble, P ^a   Chard, T ^b   Gunn, L ^b   Iles, R ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c Ctr for Repro Growth and Devmt   (United Kingdom)

Author keywords

Aneuploidies; Screening; Urinary core hCG

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; CREATININE;

ADULT; ANEUPLOIDY; ARTICLE; CREATININE URINE LEVEL; DOWN SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; HORMONE DETERMINATION; HORMONE URINE LEVEL; HUMAN; KARYOTYPE 45,X; MAJOR CLINICAL STUDY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; TRISOMY 18; TRISOMY 21; URINALYSIS;

ADULT; ANEUPLOIDY; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CREATININE; FEMALE; GESTATIONAL AGE; HUMANS; MASS SCREENING; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; REFERENCE VALUES;

EID: 0030920697     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199705)17:5<401::AID-PD40>3.0.CO;2-M     Document Type: Article

References (11)

1. Canick, J.A., Kellner, L.H., Saller, D.N., Jr, Palomaki, G.E., Walker, R.P., Osthanondh, R. (1995). Second-trimester levels of maternal urinary gonadotropin peptide in Down's syndrome pregnancy, Prenat. Diagn., 15, 739-744.
2. Cole, L.A., Kardana, A., Park, S.-Y., Braunstein, G.D. (1993). The deactivation of hCG nicking and dissociation, J. Clin. Endocrinol. Metab., 76, 704-710.
3. Cuckle, H.S., Iles, R.K., Chard, T. (1994). Urinary β-core human chorionic gonadotrophin: a new approach to Down's syndrome screening, Prenat. Diagn., 14, 953-958.
4. Cuckle, H.S., Iles, R.K., Sehmi, I.K., Chard, T., Oakey, R.E., Davies, S., Ind, T. (1995). Urinary multiple marker screening for Down's syndrome, Prenat. Diagn., 15, 745-751.
5. Hayashi, M., Kozu, H. (1995). Maternal urinary β-core fragment of hCG/creatinine ratios and fetal chromosomal abnormalities in the second trimester of pregnancy, Prenat. Diagn., 15, 11-16.
6. Lee, C.L., Iles, R.K., Shepherd, J.H., Hudson, C.N., Chard, T. (1991). The purification and development of a radioimmunoassay for β-core fragment of human chorionic gonadotrophin in urine: application as a marker of gynaecological cancer in premenopausal and postmenopausal women, J. Endocrinol., 130, 481-489.
7. Macintosh, M.C.M., Brambati, B., Chard, T., Grudzinskas, J.G. (1995). Crown-rump length in aneuploid fetuses: implications for first-trimester biochemical screening for aneuploidies, Prenat. Diagn., 15, 691-694.
8. Nisula, B.C., Blithe, D.L., Akar, A., Leport, G., Wehmann, R.E. (1989). Metabolic fate of human choriogonadotropin, J. Steroid Biochem., 33, 733-737.
9. Rotmensch, S., Liberati, M., Kardana, A., Mahoney, M., Cole, L.A. (1992). Peptide heterogeneity of human chorionic gonadotropin (hCG) and its β-subunit in Down syndrome pregnancies, Am. J. Obstet. Gynecol., 169, 1558-1562.
10. Spencer, K., Coombes, E.J., Mallard, A.S., Milford-Ward, A. (1992). Free beta human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers, Ann. Clin. Biochem., 29, 506-518.
11. Wald, D., Demsen, J., Stone, R., Cheng, R. (1993). The use of free β-hCG in antenatal screening for Down's syndrome, Br. J. Obstet. Gynaecol., 100, 550-557.